These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21592741)

  • 1. Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes.
    Pavuluri MN; Passarotti AM; Lu LH; Carbray JA; Sweeney JA
    Psychiatry Res; 2011 Jul; 193(1):28-37. PubMed ID: 21592741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone and divalproex differentially engage the fronto-striato-temporal circuitry in pediatric mania: a pharmacological functional magnetic resonance imaging study.
    Pavuluri MN; Passarotti AM; Fitzgerald JM; Wegbreit E; Sweeney JA
    J Am Acad Child Adolesc Psychiatry; 2012 Feb; 51(2):157-170.e5. PubMed ID: 22265362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy impacts functional connectivity among affective circuits during response inhibition in pediatric mania.
    Pavuluri MN; Ellis JA; Wegbreit E; Passarotti AM; Stevens MC
    Behav Brain Res; 2012 Jan; 226(2):493-503. PubMed ID: 22004983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder.
    Pavuluri MN; Henry DB; Findling RL; Parnes S; Carbray JA; Mohammed T; Janicak PG; Sweeney JA
    Bipolar Disord; 2010 Sep; 12(6):593-605. PubMed ID: 20868458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacological functional magnetic resonance imaging study probing the interface of cognitive and emotional brain systems in pediatric bipolar disorder.
    Pavuluri MN; Passarotti AM; Parnes SA; Fitzgerald JM; Sweeney JA
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):395-406. PubMed ID: 20973710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.
    Young RC; Mulsant BH; Sajatovic M; Gildengers AG; Gyulai L; Al Jurdi RK; Beyer J; Evans J; Banerjee S; Greenberg R; Marino P; Kunik ME; Chen P; Barrett M; Schulberg HC; Bruce ML; Reynolds CF; Alexopoulos GS;
    Am J Psychiatry; 2017 Nov; 174(11):1086-1093. PubMed ID: 29088928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.
    Geller B; Luby JL; Joshi P; Wagner KD; Emslie G; Walkup JT; Axelson DA; Bolhofner K; Robb A; Wolf DV; Riddle MA; Birmaher B; Nusrat N; Ryan ND; Vitiello B; Tillman R; Lavori P
    Arch Gen Psychiatry; 2012 May; 69(5):515-28. PubMed ID: 22213771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study.
    Vitiello B; Riddle MA; Yenokyan G; Axelson DA; Wagner KD; Joshi P; Walkup JT; Luby J; Birmaher B; Ryan ND; Emslie G; Robb A; Tillman R
    J Am Acad Child Adolesc Psychiatry; 2012 Sep; 51(9):867-78. PubMed ID: 22917200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study.
    Bahk WM; Shin YC; Woo JM; Yoon BH; Lee JS; Jon DI; Chung SK; Choi SK; Paik IH; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):115-21. PubMed ID: 15610953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial.
    Yatham LN; Grossman F; Augustyns I; Vieta E; Ravindran A
    Br J Psychiatry; 2003 Feb; 182():141-7. PubMed ID: 12562742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-morbid disruptive behavior disorder and aggression predict functional outcomes and differential response to risperidone versus divalproex in pharmacotherapy for pediatric bipolar disorder.
    West AE; Weinstein SM; Celio CI; Henry D; Pavuluri MN
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):545-53. PubMed ID: 22136096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fronto-limbic dysfunction in mania pre-treatment and persistent amygdala over-activity post-treatment in pediatric bipolar disorder.
    Passarotti AM; Sweeney JA; Pavuluri MN
    Psychopharmacology (Berl); 2011 Aug; 216(4):485-99. PubMed ID: 21390505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Early-Age Mania: Outcomes for Partial and Nonresponders to Initial Treatment.
    Walkup JT; Wagner KD; Miller L; Yenokyan G; Luby JL; Joshi PT; Axelson DA; Robb A; Salpekar JA; Wolf D; Sanyal A; Birmaher B; Vitiello B; Riddle MA
    J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):1008-19. PubMed ID: 26598476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled trial of valproic Acid versus risperidone in children 3-7 years of age with bipolar I disorder.
    Kowatch RA; Scheffer RE; Monroe E; Delgado S; Altaye M; Lagory D
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):306-13. PubMed ID: 25978742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
    Tohen M; Vieta E; Goodwin GM; Sun B; Amsterdam JD; Banov M; Shekhar A; Aaronson ST; Bardenstein L; Grecu-Gabos I; Tochilov V; Prelipceanu D; Oliff HS; Kryzhanovskaya L; Bowden C
    J Clin Psychiatry; 2008 Nov; 69(11):1776-89. PubMed ID: 19014751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amygdala functional connectivity predicts pharmacotherapy outcome in pediatric bipolar disorder.
    Wegbreit E; Ellis JA; Nandam A; Fitzgerald JM; Passarotti AM; Pavuluri MN; Stevens MC
    Brain Connect; 2011; 1(5):411-22. PubMed ID: 22432455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.
    Wagner KD; Redden L; Kowatch RA; Wilens TE; Segal S; Chang K; Wozniak P; Vigna NV; Abi-Saab W; Saltarelli M
    J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):519-532. PubMed ID: 19325497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.